They all can. The question is: Will all of the patients who do improve, remain improved as compared to the way they were before treatment? Even though many patients do enjoy persistent improvement, some of the patients will go back to feeling as they did prior to treatment. Much less than 1%, if any, will have symptoms that are persistently worse after T3 therapy than they were prior to T3 therapy (Q16).